Paper8554944
The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.
Roberts J and 4 others. Br J Clin Pharmacol, 1995. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers. Papers, record 8554944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554944
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiparkinson Agents | Major topic |
| Levodopa | Major topic |
| Selegiline | Major topic |
| Adult | |
| Drug Interactions | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Placebos | |
| Reference Values |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,528,851 | Variability of L-dopa absorption in man. | Aust N Z J Med | 1974 | https://conductscience.org/library/papers/4528851 | PubMed |
| 2 | 8,000,101 | Selegiline (L-deprenyl) and L-dopa treatment of Parkinson's disease: a double-blind trial. | Intern Med | 1994 | https://conductscience.org/library/papers/8000101 | PubMed |
| 3 | 6,420,516 | Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration. | J Neural Transm | 1983 | https://conductscience.org/library/papers/6420516 | PubMed |
| 4 | 3,109,430 | Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain. | Biochem Pharmacol | 1987 | https://conductscience.org/library/papers/3109430 | PubMed |
| 5 | 3,324,948 | On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. | Ann Neurol | 1987 | https://conductscience.org/library/papers/3324948 | PubMed |
| 6 | 2,775,615 | The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2775615 | PubMed |
| 7 | 2,404,503 | The influence of levodopa on gastric emptying in man. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2404503 | PubMed |
| 8 | 2,515,716 | Selegiline in the treatment of daily fluctuations in disability of parkinsonian patients with long-term levodopa treatment. | Acta Neurol Scand Suppl | 1989 | https://conductscience.org/library/papers/2515716 | PubMed |
| 9 | 2,106,391 | L-deprenyl, levodopa pharmacokinetics, and response fluctuations in Parkinson's disease. | Clin Neuropharmacol | 1990 | https://conductscience.org/library/papers/2106391 | PubMed |
| 10 | 1,549,214 | Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging. | Neurology | 1992 | https://conductscience.org/library/papers/1549214 | PubMed |
| 11 | 1,801,539 | Experience with selegiline and levodopa in advanced Parkinson's disease. | Acta Neurol Scand Suppl | 1991 | https://conductscience.org/library/papers/1801539 | PubMed |
| 12 | 1,513,186 | Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases. | Med Res Rev | 1992 | https://conductscience.org/library/papers/1513186 | PubMed |
| 13 | 8,422,661 | Effects of selegiline dosing on motor fluctuations in Parkinson's disease. | Clin Neuropharmacol | 1993 | https://conductscience.org/library/papers/8422661 | PubMed |
| 14 | 8,477,410 | The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers. | Clin Neuropharmacol | 1993 | https://conductscience.org/library/papers/8477410 | PubMed |
| 15 | 8,290,096 | Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients. | Neurology | 1994 | https://conductscience.org/library/papers/8290096 | PubMed |
| 16 | 8,302,307 | Selegiline in de novo parkinsonian patients: the Finnish study. | Mov Disord | 1993 | https://conductscience.org/library/papers/8302307 | PubMed |
| 17 | 7,202,139 | Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. | Neurology | 1981 | https://conductscience.org/library/papers/7202139 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,735,694 | Estimating Human Jejunal Effective Permeability Using Numerical Deconvolution of Oral Solution Concentration Data. | Pharm Res | 2026 | https://conductscience.org/library/papers/41735694 | PubMed |
| 27,521,014 | Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management. | CNS Drugs | 1998 | https://conductscience.org/library/papers/27521014 | PubMed |
| 26,779,024 | The Human Experience with Intravenous Levodopa. | Front Pharmacol | 2015 | https://conductscience.org/library/papers/26779024 | PubMed |
| 16,485,914 | Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16485914 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8554944
GET https://conductscience.org/api/papers/v1/8554944/authors